Dr Virginia-Maria Vlachava
Research Associate
- vlachavav@cardiff.ac.uk
- Adeilad Henry Wellcome ar gyfer Ymchwil Biofeddygol, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4XN
Cyhoeddiadau
2023
- Vlachava, V. et al. 2023. HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation. Proceedings of the National Academy of Sciences 120(49), article number: e2309077120. (10.1073/pnas.2309077120)
2021
- Vlachava, V. et al. 2021. Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus. Journal of Clinical Investigation 131(4), article number: e139296. (10.1172/JCI139296)
2018
- Patel, M., Vlachava, V., Forbes, S. K., Fielding, C. A., Stanton, R. J. and Wang, E. 2018. HCMV-encoded NK modulators: Lessons from in vitro and in vivo genetic variation. Frontiers in Immunology 9, article number: 2214. (10.3389/fimmu.2018.02214)
- Wang, E. C. Y. et al. 2018. Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses. Proceedings of the National Academy of Sciences 115(19), pp. 4998-5003. (10.1073/pnas.1720950115)
2015
- Vlachava, V., Eliopoulos, A. G. and Sourvinos, G. 2015. CD40 ligand exhibits a direct antiviral effect on Herpes Simplex Virus type-1 infection via a PI3K-dependent, autophagy-independent mechanism. Cellular Signalling 27(6), pp. 1253-1263. (10.1016/j.cellsig.2015.03.002)
2011
- Lin, B. et al. 2011. Detection of herpes simplex virus Type-1 in patients with fibrotic lung diseases. PLoS ONE 6(12), article number: e27800. (10.1371/journal.pone.0027800)
2008
- Kastrinaki, M. et al. 2008. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Annals of the Rheumatic Diseases 67(6), pp. 741-749. (10.1136/ard.2007.076174)